Johnson & Johnson

AbbVie To Buy Leukemia Drugmaker Pharmacyclics For $21BAbbVie -- based in North Chicago -- said late Wednesday that it will pay $261.25 a share for Pharmacyclics, which makes Imbruvica, a drug approved to treat three different types of blood cancers. That represents a premium of about 21 percent to the closing price of Pharmacyclics shares on Tuesday.
Chicago Man Blew Whistle On Johnson & Johnson Johnson & Johnson has agreed to pay more than $2 billion to settle some serious criminal and civil charges with the federal government. CBS 2's Jim Williams reports.
Lawsuit: Tylenol Was To Blame For Baby's DeathThe makers of Tylenol are facing a new lawsuit filed by an Illinois family on an old recall.
Self-Published Book Claims Conspiracy In Tylenol PoisoningsNew revelations have surfaced about the origin of the infamous Tylenol poisonings nearly three decades ago.
Study: Drug, Device Help Treat Heart FailureThere's good news for millions of people with mild or moderate heart failure.
Daily Weather Reports Delivered To You!SIGN UP NOW: Get daily weather reports every morning from meteorologist Steve Baskerville!
CBS Sports Radio RoundupGet your latest sports talk from across the country.

Listen Live